Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Vaccines

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    April 2025
  1. JATT LP, Mgodi NM, Buchbinder SP, Gray GE, et al
    An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant?
    N Engl J Med. 2025;392:1561-1563.
    PubMed    


    March 2025
  2. YOUNG VB
    Vaccinating against Clostridioides difficile Infection.
    N Engl J Med. 2025;392:1237-1240.
    PubMed    


    February 2025
  3. KIMATHI D, Juan-Giner A, Bob NS, Orindi B, et al
    Low-Dose Yellow Fever Vaccine in Adults in Africa.
    N Engl J Med. 2025;392:788-797.
    PubMed     Abstract available


  4. WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al
    VITT-like Monoclonal Gammopathy of Thrombotic Significance.
    N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930.
    PubMed     Abstract available


    January 2025
  5. HALL VG, Smibert OC, Sullivan SG, Lim C, et al
    Influenza Vaccination Strategies in Patients with Hematologic Cancer.
    N Engl J Med. 2025;392:306-308.
    PubMed    


    December 2024
  6. MUYEMBE JJ, Pan H, Peto R, Diallo A, et al
    Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.
    N Engl J Med. 2024;391:2327-2336.
    PubMed     Abstract available


    November 2024
  7. YOSHIDA LM, Toizumi M, Nguyen HAT, Quilty BJ, et al
    Effect of a Reduced PCV10 Dose Schedule on Pneumococcal Carriage in Vietnam.
    N Engl J Med. 2024;391:1992-2002.
    PubMed     Abstract available


  8. OLIVO-FREITES C, Miguez-Arosemena P, Olivo-Freites C, Edelman D, et al
    Susceptibility to Vaccine-Preventable Infections in Asylum Seekers.
    N Engl J Med. 2024;391:1959-1960.
    PubMed    


    October 2024
  9. WALSH EE, Perez Marc G, Falsey AR, Jiang Q, et al
    RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons.
    N Engl J Med. 2024;391:1459-1460.
    PubMed    


    September 2024
  10. GALLAGHER KE, Lucinde R, Bottomley C, Kaniu M, et al
    Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial.
    N Engl J Med. 2024 Sep 26. doi: 10.1056/NEJMoa2314620.
    PubMed     Abstract available


  11. WALENSKY RP, Baggett MV, Tran KM, Shepard JO, et al
    Case 27-2024: A 24-Year-Old Man with Pain and Dyspnea.
    N Engl J Med. 2024;391:845-852.
    PubMed    


    August 2024
  12. NACHEGA JB, Mohr EL, Dashraath P, Mbala-Kingebeni P, et al
    Mpox in Pregnancy - Risks, Vertical Transmission, Prevention, and Treatment.
    N Engl J Med. 2024 Aug 28. doi: 10.1056/NEJMp2410045.
    PubMed    


    July 2024
  13. SINHA MS, Parmet WE, Gonsalves GS
    Deja Vu All Over Again - Refusing to Learn the Lessons of Covid-19.
    N Engl J Med. 2024 Jul 24. doi: 10.1056/NEJMp2406427.
    PubMed    


  14. ROSEN CJ
    Viral Variants, Vaccinations, and Long Covid - New Insights.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMe2407575.
    PubMed    


  15. XIE Y, Choi T, Al-Aly Z
    Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras.
    N Engl J Med. 2024 Jul 17. doi: 10.1056/NEJMoa2403211.
    PubMed     Abstract available


  16. SALMON DA, Orenstein WA, Plotkin SA, Chen RT, et al
    Funding Postauthorization Vaccine-Safety Science.
    N Engl J Med. 2024;391:102-105.
    PubMed    


    June 2024

  17. Are We Prepared for Bird Flu?: ITT Episode 32.
    N Engl J Med. 2024;390:e59.
    PubMed    


    May 2024
  18. LIN DY, Du Y, Xu Y, Paritala S, et al
    Durability of XBB.1.5 Vaccines against Omicron Subvariants.
    N Engl J Med. 2024 May 29. doi: 10.1056/NEJMc2402779.
    PubMed    


  19. RUBIN EJ, Baden LR, Marrazzo J, Monto A, et al
    Audio Interview: The Current State of Avian Influenza.
    N Engl J Med. 2024 May 20. doi: 10.1056/NEJMe2406223.
    PubMed    


  20. WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al
    Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
    N Engl J Med. 2024;390:1827-1829.
    PubMed    


    April 2024
  21. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    PubMed     Abstract available


    March 2024
  22. HSIAO A, Fireman B, Klein NP
    Recombinant Influenza Vaccine in Adults under 65 Years of Age. Reply.
    N Engl J Med. 2024;390:1156.
    PubMed    


  23. WOO EJ, Hulse AN
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155-1156.
    PubMed    


  24. HAVIARI S, Massonnaud CR, Dupont A
    Recombinant Influenza Vaccine in Adults under 65 Years of Age.
    N Engl J Med. 2024;390:1155.
    PubMed    


  25. RASMUSSEN SA, Jamieson DJ
    Maternal RSV Vaccine - Weighing Benefits and Risks.
    N Engl J Med. 2024;390:1050-1051.
    PubMed    


  26. DIEUSSAERT I, Hyung Kim J, Luik S, Seidl C, et al
    RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.
    N Engl J Med. 2024;390:1009-1021.
    PubMed     Abstract available


    February 2024
  27. MONTO AS, Zambon M, Weir JP
    The End of B/Yamagata Influenza Transmission - Transitioning from Quadrivalent Vaccines.
    N Engl J Med. 2024 Feb 28. doi: 10.1056/NEJMp2314801.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.